Human albumin
Trade name
Albumin
Dosage form
solution for infusion
Shelf life
5 years.
Manufacturer
NPO Microgen» 44, Gruzinskaya str., Nizhny Novgorod, Nizhny Novgorod region, 603950 Russia 177, Bratskaya str., Perm, Perm Territory, 614089 Russia 8, Ivanovskogo str., Tomsk, Tomsk Region, 634040 Russia 634040 105 Novorossiyskaya str., Ufa, Republic of Bashkortostan, 450014 Russia
Presentation
5%, 10%, 20% solution for infusion in 50 ml, 100 ml, 200 ml and 400 ml glass bottles (vials) for blood products, transfusion and infusion preparations. 1 bottle (vial) in each cardboard package with a package insert.
Ingredients
5% solution for infusion
- albumin derived from plasma for fractionation, 5%.
Excipients:
- sodium caprylate (1.4-1.7) g/l;
- sodium chloride (90-160) mmol/l;
- water for injections up to 1 l.
10% solution for infusion
- albumin derived from plasma for fractionation, 10%.
Excipients:
- sodium caprylate (2.8-3.4) g/l;
- sodium chloride (90-160) mmol/l;
- water for injections up to 1 l.
20% solution for infusion
- albumin derived from plasma for fractionation, 20%.
Excipients:
- sodium caprylate (5.7-6.4) g/l;
- sodium chloride (90-160) mmol/l; - water for injections up to 1 l.
Indications
Shock (traumatic, operational, toxic); burns accompanied by dehydration and thickening of blood; acute blood loss; purulent inflammatory diseases; liver disease (with failure of the albumin synthesis function); kidney disease (nephritis, nephrotic syndrome).
Hypoproteinemia, hypoalbuminemia of various origins developed due to malnutrition, reduction of albumin in plasma below 30 g/l, the level of the colloid oncotic pressure below 15 mmHg with a decrease of total protein below 50 g/l; disease of the gastrointestinal system with malabsorption or bowel obstruction.
During surgeries with the use of cardiopulmonary bypass; therapeutic plasmapheresis; hemolytic disease of newborns during the exchange transfusion.
During the presurgical hemodilution and collection of autologous blood components; cerebral edema.